p.51 抽出テキスト

August 1, 2017 Circulation. 2017;136:e60–e122. DOI: 10.1161/CIR.0000000000000499 e110

520.	 Raj SR, Black BK, Biaggioni I, et al. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation. 2009;120:725–34. 521.	 Ross AJ, Ocon AJ, Medow MS, et al. A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome. Clin Sci. 2014;126:289–96. 522.	 Figueroa RA, Arnold AC, Nwazue VC, et al. Acute volume loading and exercise capacity in postural tachycardia syndrome. J Appl Physiol. 2014;117:663–8. 523.	 Garland EM, Robertson D. Chiari I malformation as a cause of orthostatic intolerance symptoms: a media myth? Am J Med. 2001;111: 546–52. 524.	 Hubsch C, Baumann C, Hingray C, et al. Clinical classification of psychogenic non-epileptic seizures based on video-EEG analysis and automatic clustering. J Neurol Neurosurg Psychiatr. 2011;82:955–60. 525.	 Iglesias JF, Graf D, Forclaz A, et al. Stepwise evaluation of unexplained syncope in a large ambulatory population. Pacing Clin Electrophysiol. 2009;32 Suppl 1:S202–6. 526.	 Elliott JO, Charyton C. Biopsychosocial predictors of psychogenic nonepileptic seizures. Epilepsy Res. 2014;108:1543–53. 527.	 Mayor R, Howlett S, Grünewald R, et al. Long-term outcome of brief augmented psychodynamic interpersonal therapy for psychogenic nonepileptic seizures: seizure control and health care utilization. Epilepsia. 2010;51:1169–76. 528.	 Mayor R, Brown RJ, Cock H, et al. Short-term outcome of psychogenic non-epileptic seizures after communication of the diagnosis. Epilepsy Behav. 2012;25:676–81. 529.	 LaFrance WC Jr, Keitner GI, Papandonatos GD, et al. Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures. Neurology. 2010;75:1166–73. 530.	 Goldstein LH, Chalder T, Chigwedere C, et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology. 2010;74:1986–94. 531.	 Reuber M, Burness C, Howlett S, et al. Tailored psychotherapy for patients with functional neurological symptoms: a pilot study. J Psychosom Res. 2007;63:625–32. 532.	 Santos NdO, Benute GRG, Santiago A, et al. Psychogenic non-epileptic seizures and psychoanalytical treatment: results. Rev Assoc Med Bras. 2014;60:577–84. 533.	 Zeng W, Deng H. Cough syncope: constrictive pericarditis. Intern Med. 2013;52:463–5. 534.	 Guaricci AI, Basso C, Tarantini G. Recurrent syncope on effort due to concealed constrictive pericarditis. Eur Heart J. 2013;34:1817 535.	 Dhar R, Duke RJ, Sealey BJ. Cough syncope from constrictive pericarditis: a case report. Can J Cardiol. 2003;19:295–6. 536.	 Vasquez AF, Seger JJ. An uncommon case of heart failure. South Med J. 2009;102:1183–5. 537.	 Sviggum HP, Kopp SL, Rettke SR, et al. Perioperative complications in patients with left ventricular non-compaction. Eur J Anaesthesiol. 2011;28:207–12. 538.	 Koh C, Lee PW, Yung TC, et al. Left ventricular noncompaction in children. Congenit Heart Dis. 2009;4:288–94. 539.	 Enriquez SG, Entem FR, Cobo M, et al. Uncommon etiology of syncope in a patient with isolated ventricular noncompaction. Pacing Clin Electrophysiol. 2007;30:577–9. 540.	 Rovetta R, Bonadei I, Vizzardi E, et al. Syncope as presentation of recurrent Tako-Tsubo cardiomyopathy. Minerva Cardioangiol. 2014;62:366–8. 541.	 Yoshida T, Hibino T, Fujimaki T, et al. Transient mid-ventricular ballooning syndrome complicated by syncope: a variant of tako-tsubo cardiomyopathy. Int J Cardiol. 2009;135:e20–e23. 542.	 Tisserand G, Gil H, Méaux-Ruault N, et al. [Clinical features of pulmonary embolism in elderly: a comparative study of 64 patients]. Rev Med Interne. 2014;35:353–6. 543.	 Chakraborty A, Jutley G. Isolated syncope - an uncommon presenting feature of pulmonary embolism. Acute Med. 2011;10:79–80. 544.	Linhart A, Kampmann C, Zamorano JL, et al. Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J. 2007;28:1228–35. 545.	 Acharya D, Robertson P, Kay GN, et al. Arrhythmias in Fabry cardiomyopathy. Clin Cardiol. 2012;35:738–40. 546.	 Hwang YT, Tseng CD, Hwang JJ, et al. Cardiac amyloidosis presenting

as sick sinus syndrome and intractable heart failure: report of a case. J Formos Med Assoc. 1993;92:283–7. 547.	 Velazquez-Ceceña JL, Lubell DL, Nagajothi N, et al. Syncope from dy-

namic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease. Tex Heart Inst J. 2009;36:50–4. 548.	 Strobel JS, Fuisz AR, Epstein AE, et al. Syncope and inducible ventricular fibrillation in a woman with hemochromatosis. J Interv Card Electrophysiol. 1999;3:225–9. 549.	 Akashi R, Kizaki Y, Kawano H, et al. Seizures and syncope due to complete atrioventricular block in a patient with acute myocarditis with a normal left ventricular systolic function. Intern Med. 2012;51:3035–40. 550.	 Mancio J, Bettencourt N, Oliveira M, et al. Acute right ventricular myocarditis presenting with chest pain and syncope. BMJ Case Rep. 2013;2013. 551.	 Patel RAG, DiMarco JP, Akar JG, et al. Chagas myocarditis and syncope. J Cardiovasc Magn Reson. 2005;7:685–8. 552.	 Lopez JA, Treistman B, Massumi A. Myocarditis-associated ventricular fibrillation. An unusual cause of syncope in Wolff-Parkinson-White syndrome. Tex Heart Inst J. 1995;22:335–8. 553.	 Dhar KL, Adlakha A, Phillip PJ. Recurrent seizures and syncope, ventricular arrhythmias with reversible prolonged Q-Tc interval in typhoid myocarditis. J Indian Med Assoc. 1987;85:336–7. 554.	 Manek M, Kulkarni A, Viera A. Hint of Lyme, an uncommon cause of syncope. BMJ Case Rep. 2014;2014 555.	 Ciesielski CA, Markowitz LE, Horsley R, et al. Lyme disease surveillance in the United States, 1983–1986. Rev Infect Dis. 1989;11 suppl 6:S1435–41. 556.	 Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375:1388–402. 557.	 de Souza ACJ, Salles G, Hasslocher-Moreno AM, et al. Development of a risk score to predict sudden death in patients with Chaga’s heart disease. Int J Cardiol. 2015;187:700–4. 558.	 Leite LR, Fenelon G, Paes AT, et al. The impact of syncope during clinical presentation of sustained ventricular tachycardia on total and cardiac mortality in patients with chronic Chagasic heart disease. Arq Bras Cardiol. 2001;77:439–52. 559.	 Martinelli Filho M, Sosa E, Nishioka S, et al. Clinical and electrophysiologic features of syncope in chronic chagasic heart disease. J Cardiovasc Electrophysiol. 1994;5:563–70. 560.	 Josephson ME, Wellens HJJ. Syncope in a patient with myotonic dystrophy. Heart Rhythm. 2015;12:1882–3. 561.	 Finsterer J, Stöllberger C, Gencik M, et al. Syncope and hyperCKemia as minimal manifestations of short CTG repeat expansions in myotonic dystrophy type 1. Rev Port Cardiol. 2015;34:361–4. 562.	 Brescia ST, Rossano JW, Pignatelli R, et al. Mortality and sudden death in pediatric left ventricular noncompaction in a tertiary referral center. Circulation. 2013;127:2202–8. 563.	 Bhatia NL, Tajik AJ, Wilansky S, et al. Isolated noncompaction of the left ventricular myocardium in adults: a systematic overview. J Card Fail. 2011;17:771–8. 564.	 Hernández-Luis C, García-Morán E, Rubio-Sanz J, et al. [Kearns-Sayre syndrome: recurrent syncope and atrial flutter]. Rev Esp Cardiol. 2007;60:89–90. 565.	 Letsas KP, Efremidis M, Pappas LK, et al. Pathophysiology and management of syncope in Kearns-Sayre syndrome. Am Heart Hosp J. 2006;4:301–2. 566.	 Konety SH, Horwitz P, Lindower P, et al. Arrhythmias in tako-tsubo syndrome–benign or malignant? Int J Cardiol. 2007;114:141–4. 567.	 Alampi G, Nuzzo F, Ronchi E, et al. [Lipomatous hypertrophy and Lev- Lenègre disease]. Cardiologia. 1986;31:67–70. 568.	 Bracchi G, Vezzoli F, Rossi L. [The pathology of the primitive or idiopathic block (disease of Lenègre and Lev). Critical review and personal casuistic (author’s transl)]. G Ital Cardiol. 1973;3:509–18. 569.	 Barlow JB. Lev’s or Lenègre’s disease? J Cardiovasc Electrophysiol. 1994;5:897 570.	 Stéphan E, Aftimos G, Allam C. Familial fascicular block: histologic features of Lev’s disease. Am Heart J. 1985;109:1399–401. 571.	 Rasmussen KS, Paulsen SM. [Total atrioventricular block caused by dystrophic calcification: Lev’s disease]. Ugeskr Laeg. 1980;142:2986–7. 572.	 Dubrey SW, Hawkins PN, Falk RH. Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart. 2011;97:75–84. 573.	 Kaul P, Adluri K, Javangula K, et al. Successful management of multiple per-

manent pacemaker complications—infection, 13 year old silent lead perforation and exteriorisation following failed percutaneous extraction, superior vena cava obstruction, tricuspid valve endocarditis, pulmonary embolism and prosthetic tricuspid valve thrombosis. J Cardiothorac Surg. 2009;4:12

Downloaded from http://ahajournals.org by on October 7, 2026